A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
Southampton logs onto $1.3m fund
The university has partnered regional business advocate Solent LEP to launch an accelerator fund aimed at generating 16 internet-focused spinouts by March 2019.
Johns Hopkins targets $65m for therapeutics
The Bluefield Innovations vehicle will back early-stage Johns Hopkins projects over five years with a view to eventually spinning out or licensing promising ideas.
Edmits studies $855,000 pre-seed round
SNHU has backed edtech developer Edmit through the Rethink Education fund, a vehicle also backed by Rethink Education.
Inozyme signs up for $49m series A
Novo and Sanofi have backed a series A round for Inozyme Pharma, which is developing treatments for rare diseases affecting infants based on research at Yale.
Sam Labs computes $6.75m series A
Touchstone Innovations has co-led a $6.75m series A round for edtech developer Sam Labs after it pumped $2.9m into the business in May 2016.
Scipio collects $1.4m seed round
Multi-university venture fund Quadrivium I has backed Scipio’s search for a simplified preparation fluid to aid single-cell genomics research.
The Pittsburgh spinout is building a precision diagnostic platform that uses genomics to underpin research into conditions such as chronic pancreatic disease.
Apellis hears stock market call
Pennsylvania spinout Apellis Pharmaceuticals has floated on the Nasdaq Global Select Market after raising $150m in its initial public offering.
Dynamic Biosensors detects $6m
Unternehmertum Venture Capital Partners has returned to back a series B round for Dynamic Biosensors, a spinout from Technical University of Munich.
The National University of Singapore spinout has secured an undisclosed amount to bring its blockchain platform through public testing scheduled for December 2017.
Deakin lets Genie out of the bottle
A new spinout from Deakin University will market a personal assistant and marketing platform already used on campus.
Arsanis chases bigger IPO dream
EMBL-backed Arsanis hopes to sell 3,125,000 shares priced at $15 to $17 and raise a total of up to $61m in its initial public offering.
The cash will be used for a recruitment drive as QCI begins to ramp up the development of modules that could eventually be used for general purpose quantum computing.
Immunotherapy developer Arcus Biosciences, backed by Stanford University, has raised series C funding from a GV-led consortium that included Celgene and Taiho.
Graphcore processes $50m in series C cash
Graphcore, whose roots can be traced back to University of Bristol, has added $50m to its coffers thanks to a series C round backed by Bosch, Dell and Samsung.
My transition from basic research to a career in technology transfer
Su Jun Lim-Higbie, technology manager at Michigan State University’s tech transfer office, describes her journey from pipetting to commercialising.
Manchester engineers Atomic Mechanics
Atomic Mechanics has been spun out of Manchester to couple semiconductors with graphene to build highly reactive pressure sensors.
The board has recommended Touchstone shareholders accept the $641m all-shares offer from commercialisation peer IP Group before Touchstone ceases trading on Aim on December 11.
